Getting at MYC through RAS

被引：32

作者：

Bachireddy, P

Bendapudi, PK

Felsher, DW

机构：

[1] Stanford Univ, Sch Med, Div Med Oncol, Dept Med, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA

来源：

CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 12期

关键词：

D O I：

10.1158/1078-0432.CCR-05-0534

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4278 / 4281

页数：4

共 35 条

[1] Prospects for anti-Ras drugs [J].

Ahmadian, MR .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) :511-518

[2]

[Anonymous], 2002, PRINCIPLES PRACTICE

[3] MOLECULAR THEMES IN ONCOGENESIS [J].

BISHOP, JM .

CELL, 1991, 64 (02) :235-248

[4]

BOS JL, 1989, CANCER RES, V49, P4682

[5] Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies [J].

Cortes, J ;

Albitar, M ;

Thomas, D ;

Giles, F ;

Kurzrock, R ;

Thibault, A ;

Rackoff, W ;

Koller, C ;

O'Brien, S ;

Garcia-Manero, G ;

Talpaz, M ;

Kantarjian, H .

BLOOD, 2003, 101 (05) :1692-1697

[6] c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations [J].

D'Cruz, CM ;

Gunther, EJ ;

Boxer, RB ;

Hartman, JL ;

Sintasath, L ;

Moody, SE ;

Cox, JD ;

Ha, SI ;

Belka, GK ;

Golant, A ;

Cardiff, RD ;

Chodosh, LA .

NATURE MEDICINE, 2001, 7 (02) :235-239

[7]

Dang CV, 1999, MOL CELL BIOL, V19, P1

[8] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[9] Targeting ras signalling pathways in cancer therapy [J].

Downward, J .

NATURE REVIEWS CANCER, 2003, 3 (01) :11-22

[10] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

← 1 2 3 4 →